SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
+1.21%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$290M
AUM Growth
+$290M
(-2.8%)
Cap. Flow
-$23.4M
Cap. Flow
% of AUM
-8.06%
Top 10 Holdings %
Top 10 Hldgs %
37.09%
Holding
61
New
12
Increased
15
Reduced
10
Closed
19
Top Buys
| 1 |
Select Medical
SEM
|
$9.97M |
| 2 |
Smith & Nephew
SNN
|
$8.57M |
| 3 |
UnitedHealth
UNH
|
$6.22M |
| 4 |
Becton Dickinson
BDX
|
$6.15M |
| 5 |
HCA Healthcare
HCA
|
$6.07M |
Top Sells
| 1 |
SPDR S&P Biotech ETF
XBI
|
$13.5M |
| 2 |
Universal Health Services
UHS
|
$11M |
| 3 |
Tenet Healthcare
THC
|
$9.69M |
| 4 |
Zimmer Biomet
ZBH
|
$9.65M |
| 5 |
Biogen
BIIB
|
$6.93M |
Sector Composition
| 1 | Healthcare | 99.19% |
| 2 | Energy | 0.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Bruker
BRKR
$5.04B
| $5.86M | 1.4% |
75,000
-20,000
| -21% | -$1.56M |
|
27
Regeneron Pharmaceuticals
REGN
$61.3B
| $5.79M | 1.38% |
+160,000
| New | +$5.79M |
|
28
Molina Healthcare
MOH
$9.8B
| $5.43M | 1.3% |
20,000
-20,000
| -50% | -$5.43M |
|
29
Thermo Fisher Scientific
TMO
$186B
| $5.36M | 1.28% |
+15,000
| New | +$5.36M |
|
30
BioMarin Pharmaceuticals
BMRN
$11.2B
| $5.02M | 1.2% |
65,000
+10,000
| +18% | +$773K |
|
31
Stryker
SYK
$150B
| $4.88M | 1.17% |
12,500
-12,500
| -50% | -$4.88M |
|
32
Humana
HUM
$36.5B
| $4.86M | 1.16% |
12,500
-12,500
| -50% | -$4.86M |
|
33
Hologic
HOLX
$14.9B
| $4.43M | 1.06% |
60,000
+10,000
| +20% | +$738K |
|
34
Option Care Health
OPCH
$4.65B
| $3.76M | 0.9% |
+155,000
| New | +$3.76M |
|
35
Community Health Systems
CYH
$387M
| $3.69M | 0.88% |
+315,000
| New | +$3.69M |
|
36
Maravai LifeSciences
MRVI
$350M
| $3.68M | 0.88% |
+75,000
| New | +$3.68M |
|
37
Bio-Techne
TECH
$8.5B
| $3.63M | 0.87% |
+7,500
| New | +$3.63M |
|
38
Quest Diagnostics
DGX
$20.3B
| $3.63M | 0.87% |
+6,000
| New | +$3.63M |
|
39
Grifois
GRFS
$6.78B
| $2.92M | 0.7% |
+200,000
| New | +$2.92M |
|
|
LHCG
40
DELISTED
LHC Group LLC
LHCG
| $2.35M | 0.56% |
+15,000
| New | +$2.35M |
|
41
Acadia Healthcare
ACHC
$2.12B
| $1.21M | 0.29% |
+18,893
| New | +$1.21M |
|
42
Agilent Technologies
A
$35.6B
| – | – |
-30,000
| Closed | -$4.43M |
|
43
AbbVie
ABBV
$374B
| – | – |
-20,000
| Closed | -$2.25M |
|
44
argenx
ARGX
$43.6B
| – | – |
-6,000
| Closed | -$1.81M |
|
|
45
Biogen
BIIB
$20.5B
| – | – |
-20,000
| Closed | -$6.93M |
|
46
Bristol-Myers Squibb
BMY
$96.5B
| – | – |
-85,000
| Closed | -$5.68M |
|
47
Cardinal Health
CAH
$35.5B
| – | – |
-65,000
| Closed | -$3.71M |
|
48
Illumina
ILMN
$15.8B
| – | – |
-8,000
| Closed | -$3.79M |
|
49
Qiagen
QGEN
$10.2B
| – | – |
-45,000
| Closed | -$2.18M |
|
50
Sana Biotechnology
SANA
$721M
| – | – |
-63,446
| Closed | -$1.25M |
|